Guidelines for treatment of HIV infected adults in Europe
News
20 February 2020
Risk of reactivation of Hepatitis B with corticosteroids
In a retrospective territory-wide study from Hong Kong patients who were negative for Hepatitis B surface antigen (HBsAg) who received corticosteroids were evaluated for the risk of seroreversion. Read more
20 February 2020
Switch to TAF did not affect central nervous system (CNS) HIV infection
20 HIV-infected patients on suppressive antiretroviral treatment who switched their backbone treatment from emtricitabine/ tenofovir disoproxil fumarate (FTC/TDF) or abacavir/ lamivudine (ABC/3TC) to FTC/tenofovir alafenamide (TAF) were evaluated for changes in their central nervous HIVinfections. Read more
EACS Guidelines
Magazine